BPC-157 vs Semaglutide
Related research areas, distinct mechanisms. Live $/mg pricing across every tracked vendor.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Both surface in research conversations about gut-axis health — BPC-157 in gastrointestinal mucosal healing, semaglutide in GLP-1-mediated gastric emptying and appetite regulation.
BPC-157 is a tissue-repair peptide derived from gastric protective protein. Semaglutide is a GLP-1 receptor agonist studied for glycemic control and weight management. They share no mechanistic overlap and target different research goals.
BPC-157
Tissue-repair research peptide
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Welli Labs US | B | Operational | $19.99 ◎ Best $/mg | $4.00 | In stock | Buy with code → | |
| Modified Aminos US | B- | Watch | $39.99 ▲ 100.1% | $8.00 | In stock | Visit → | |
| Research Peptides Europe EU | A | Operational | $45.35 ▲ 126.9% | $9.07 | In stock | Visit → | |
| Core Peptides US | A | Operational | $52.00 ▲ 160.1% | $10.40 | In stock | Visit → |
Semaglutide
GLP-1 agonist for metabolic research
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Welli Labs US | B | Operational | $29.99 ◎ Best $/mg | $6.00 | In stock | Buy with code → |
About BPC-157
BPC-157 is a synthetic peptide derived from a protective protein found in gastric juice. Widely studied in preclinical models for tendon, ligament, and gastrointestinal tissue recovery.
About Semaglutide
A once-weekly GLP-1 receptor agonist studied for glycemic control and weight loss. Approved as a prescription drug in many jurisdictions; research-peptide vendors supply the compound for laboratory use.